Knowledge on PEP among clinical medical students in developing countries is very low calling for inclusion of PEP in HIV curricula.
Continue readingFew Medical Students in Developing Countries Aware of HIV Prevention Drugs
HEALTH NEWS: AIDS Progress & Awareness
Health News: College Campuses receive HIV Awareness from Love Heals Advocates, HIV Progression spotted on Charlie Sheen from Facial Skin Lesions, Recent Progress against Aids Marked in World AIDS Day at Palm Springs
Continue readingVIDEO: The Science of HIV & AIDS
An extremely informative video on the science of HIV and AIDS made by AsapScience on Youtube
Continue readingNew Integrase Inhibitors Better In Controlling HIV Replication than Other Antiretrovirals
Availability of new integrase inhibitors offers better opportunities to improve efficiency of cART and PEP in controlling HIV replication.
Continue readingNews: Better Life For Local HIV Patients; WHO Reports Highest Cases of HIV in Eastern Europe; HIV Prophylaxis can help millions
In the news -Today reports better Life For Singaporean HIV Patients; Highest cases of HIV in Eastern Europe reported by WHO; The CDC in the US says HIV Prophylaxis can help millions
Continue readingThe ABCs of Hepatitis
A short guide to the viruses from the Hepatitis Family: Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D & Hepatitis E.
Continue readingHIV PEP drugs: Truvada® combination therapy
Truvada® is commonly used in combination with Isentress® for PEP due to the effectiveness and lack of negative interaction between the two drugs. Learn more in this detailed guide.
Continue readingHIV & the health care system: Lessons from the Greek crisis
Overspending, corruption, and tax avoidance seem to have little to do with HIV rates. In 2012, the world watched stunned as Greece’s economy collapsed. Frantic negotiating with the EU seemed to have rescued the failing state, imposing strict austerity measures on the one prosperous nation. Greece’s unemployment rose to 20%. In the younger demographic it… Continue reading
HIV PEP drugs: Isentress® (Raltegravir) intergrase inhibitor
Isentress® is one of the newest classes of antiretrovirals, the intergrase inhibitors. This drug disables the HIV intergrase protein which is responsible for integrating the viral genome into the human chromosome and causing the chronic incurable infection. Developed by Merck and Co, it was approved for adult use in 2007 by the FDA and use… Continue reading
HIV Post-exposure Prophylaxis: Future Research Methodological Challenges and Potential Approaches
Research has played a vital role in changing the face of the medical field. From untreatable diseases to highly contagious diseases, research made wondrous achievements and solved the previously unsolvable. The research on HIV has also provided us with life-saving treatments like a prophylaxis from HIV. The WHO (World Health Organization) convened a meeting in… Continue reading